Form 4 for NTRA Natera, Inc.
Accepted 2025-12-16 00:00:00 ET · period of report 2025-12-12 · accession 0002010019-25-000016 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-12-16 | 2025-12-12+ | NTRA | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | G - Gift | $0.00 | -295 | 126.5K | -0.2% | $0 |
| D | 2025-12-16 | 2025-12-12 | NTRA | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale+OE | $230.76 | -4,692 | 113.1K | -4% | -$1.08M |
| DM | 2025-12-16 | 2025-12-12 | NTRA | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | M - OptEx | $9.59 | +22.4K | 117.8K | +23% | +$214.6K |
| D | 2025-12-16 | 2025-12-10 | NTRA | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | M - OptEx | $0.00 | -22.4K | 5,125 | -81% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-12 | G | D | 180 | $0.00 | 108,881 | D | — | — | (F1) Represents a charitable contribution by the Reporting Person. |
| 2 | Common | Common Stock | 2025-12-12 | S | D | 4,692 | $230.76 | 113,065 | D | — | — | (F2) The sale of these shares was effected in order to cover the exercise price and satisfy tax withholding and remittance obligations in connection with the exercise of expiring options. |
| 3 | Common | Common Stock | 2025-12-12 | M | A | 13,500 | $9.59 | 126,565 | D | — | — | |
| 4 | Common | Common Stock | 2025-12-15 | G | D | 115 | $0.00 | 126,450 | D | — | — | (F1) Represents a charitable contribution by the Reporting Person. |
| 5 | Common | Common Stock | 2025-12-12 | M | A | 8,876 | $9.59 | 117,757 | D | — | — | |
| 6 | Derivative | Stock Option (right to buy) | 2025-12-10 | M | D | 22,376 | $0.00 | 5,125 | D | $9.59 · — to 2026-04-07 | 22,376 Common Stock | (F3) The options exercised were composed of 13,500 incentive stock options and 8,876 non-qualified stock options. (F4) The option shares are fully exercisable. |